·
2 Min Read

Aug. 19, 2022: Advocacy Update other news

Action needed to increase treatment for youth substance use and more in the latest Advocacy Update other news.

Advocacy Update
Female with tissue receiving news
·
4 Min Read

Court OKs denying coverage for mental health, substance-use care

A deeply flawed federal court ruling that gives payers a free pass to deny medically necessary care must be reconsidered by full nine-judge panel.

Judicial Advocacy
·
2 Min Read

May 27, 2022: State Advocacy Update

Wisconsin jails and prisons take different paths to treatment for opioid use disorder and more in the latest State Advocacy Update.

Advocacy Update
·
4 Min Read

Why person-centered care is needed to help patients with pain

Arbitrary limits on opioid prescribing have failed patients. Learn why an individualized approach is pivotal.

Behavioral Health
·
2 Min Read

AMA statement on overdose deaths reaching over 100,000 in past year

The AMA again is asking state and federal policymakers to embrace steps that will save lives by ensuring evidence-based treatment and harm reduction to patients.

Press Releases
·
5 Min Read

Access to treatment is key in addressing drug-overdose epidemic

Learn what’s driving inequities in the drug-overdose epidemic and why giving patients proven treatments is more effective than incarceration.

Behavioral Health
·
15 Min Read

Shifting the conversation about substance use disorder with Bobby Mukkamala, MD

AMA's Moving Medicine series features physician voices and achievements. Learn more in this discussion with Bobby Mukkamala, MD, on substance use disorder.

series
Behavioral Health
Moving Medicine Video Update
·
4 Min Read

April 1, 2022: Advocacy Update other news

Upcoming webinars on the overdose epidemic and out-of-network payment process and more in the latest Advocacy Update other news.

Advocacy Update
Person in grocery aisle
·
4 Min Read

Removing naloxone’s Rx status is an essential step to save lives

As the drug-overdose epidemic worsens, there is no moral, medical or safety-related reason for keeping naloxone locked under prescription regulations.

Behavioral Health